When ankle cartilage damage warrants OATS

If a consultant has raised OATS as an option, the question on most patients' minds is straightforward: why not just use the simpler procedure? The answer lies largely in the size of the cartilage defect — and what different techniques can realistically achieve inside it.

Osteochondral lesions of the talus (talar OCD) are focal areas of damage affecting both the cartilage surface and the underlying bone of the ankle's main weight-bearing dome. Because talar cartilage is thin, avascular, and under considerable load with every step, these lesions do not repair themselves reliably. Left untreated, they tend to cause progressive pain, swelling, and mechanical symptoms such as catching or locking in the joint.

Defect area is the central decision pivot in surgical planning. Lesions below approximately 1.5 cm² (150 mm²) are generally managed first with marrow-stimulation techniques — principally microfracture or arthroscopic drilling — which carry lower surgical complexity. At or above that threshold, published evidence consistently supports moving to a restorative procedure, most commonly OATS, because microfracture failure rates rise sharply once the defect exceeds this size. Lesion morphology also matters: uncontained defects that lack an intact surrounding cartilage rim tend to do poorly with marrow stimulation regardless of size.

OATS — osteochondral autograft transfer — addresses this by transplanting one or more cylindrical plugs of intact hyaline cartilage, harvested from a low-load region of the patient's own knee, directly into the prepared talar defect. The aim is to restore the native tissue type rather than rely on a fibrocartilage scar, which is what marrow-stimulation techniques produce. The medial talar dome is the most common lesion location, accounting for 57–70% of cases, a detail that carries its own access-planning implications explored in the next section.

What microfracture delivers — and where it runs out

The biological ceiling is the starting point. Microfracture works by perforating the subchondral bone so that marrow contents flood the defect and form a so-called super-clot. What matures from that clot is fibrocartilage — a scar-like tissue that is softer, less resilient to shear, and structurally different from the native hyaline cartilage it replaces. Under the repetitive load of an ankle joint, fibrocartilage tends to break down over time rather than hold its ground.

For small, contained lesions on the medial talar dome, that trade-off has historically been acceptable. Pooled data from systematic reviews suggest overall satisfactory outcomes in roughly 75–80% of microfracture cases in talar OCD — a respectable figure for a procedure with comparatively low surgical complexity. The limitation is that this average masks a steep size-dependency: outcomes decline sharply once defect area rises above approximately 1.5 cm², and they deteriorate further in the presence of subchondral cysts or uncontained shoulder morphology. Defect size is the strongest single predictor of microfracture failure.

A further concern applies to patients who have already had one unsuccessful microfracture attempt. Repeated procedures damage the subchondral bone plate — the structural layer that underpins the cartilage surface — and this damage can compromise results from any subsequent repair, including OATS. Avoiding a second round of marrow stimulation in an above-threshold lesion is therefore not simply a matter of efficiency; it is a reason to plan the most appropriate procedure first.

How OATS outcomes compare with the microfracture baseline

The clearest direct comparison in the literature is the randomised controlled trial by Gudas and colleagues, which allocated talar OCD patients to either OATS or microfracture and followed them to roughly four years. OATS achieved good or excellent clinical outcomes in approximately 94% of patients; microfracture achieved 52%. That 42-percentage-point gap is not a marginal difference — it represents a near-doubling of favourable results in the same patient population, managed by the same surgical team.

Pooled estimates from systematic reviews, including the Zengerink series, place OATS and mosaicplasty success rates at 85–94% across published case series. Microfracture, by comparison, sits at around 75–80% overall — and as covered above, that average declines further once defect size, cysts, or uncontained morphology enter the picture. The Gudas figures are therefore not an outlier; they sit at the upper end of a consistent pattern.

The reason the gap exists is structural. OATS plugs carry native hyaline cartilage into the defect, complete with its organised collagen architecture and stiffness characteristics matched to load-bearing talar anatomy. Microfracture produces fibrocartilage, which T2-mapping MRI has shown carries a distinct superficial relaxation signal compared with normal cartilage — imaging evidence of a tissue type that will behave differently under cyclic ankle loading. That difference in material properties, not differences in surgical technique or follow-up duration, is what drives the outcome divergence.

One honest caveat belongs here: talar OATS data extending beyond ten years remain limited compared with the deeper long-term record for knee mosaicplasty. The medium-term trajectory consistently favours OATS for above-threshold lesions, but patients should understand that the evidence base matures further with time.

Surgical trade-offs: donor-site morbidity and operative access

Two surgical realities specific to ankle OATS deserve honest discussion before any decision is made.

The first concerns the donor site. Osteochondral plugs are harvested from a non-weight-bearing zone of the knee — typically the lateral femoral condyle or intercondylar notch. For most patients this is well tolerated, but published estimates suggest approximately 10–25% report persistent donor-site knee symptoms at medium-term follow-up. That trade-off is entirely absent with microfracture, where no second joint is involved. The benefit of restoring native hyaline cartilage at the ankle must be weighed against it at assessment.

The second concerns access. Most talar OCD lesions sit on the posteromedial dome, a position partly shielded by the medial malleolus and difficult to reach through a standard ankle arthroscope. To place plugs accurately in this location, surgeons frequently perform a medial malleolar osteotomy: a controlled cut through the inner ankle bone that hinges it aside and opens a direct line to the defect, before being fixed back with screws at the close of the procedure.

Lamb and colleagues reported outcomes in 62 patients who underwent this access step alongside talar OATS. At a median follow-up of 34.5 months, 94% were asymptomatic at the osteotomy site, and median radiographic healing was apparent by six weeks. Six per cent reported residual osteotomy pain — a figure the authors cited transparently. The osteotomy adds operative complexity and extends the overall recovery programme, but in experienced hands the published healing record is reassuring.

Both considerations — knee donor-site morbidity and osteotomy recovery — form the practical counterweight to OATS's cartilage quality advantage, and both should be addressed directly at the pre-operative consultation.

Lesion characteristics that change the decision

Not every talar OCD lesion that exceeds the 1.5 cm² threshold is a straightforward OATS case. Lesion morphology — particularly cyst formation, fragment viability, and containment — can redirect the surgical plan considerably.

Where subchondral cysts lie beneath an intact cartilage surface, retrograde drilling offers a distinct marrow-stimulation pathway. Unlike standard antegrade microfracture, retrograde access avoids any disruption to the cartilage cap above the cyst. A systematic review by Artioli and colleagues (2023) identified this as a meaningful option for the cystic-but-surface-intact subgroup — a category standard OATS algorithms do not specifically address.

Where imaging identifies a primary osteochondral fragment that is viable and fixable — loosely detached rather than fragmented — the LDFF (lift, drill, fill and fix) arthroscopic technique can preserve the native fragment entirely without knee donor harvest. Lambers et al. (2019) reported CT-confirmed union in 92% of 27 ankles at one year, with NRS pain during running falling from 7.8 to 2.9. For this specific subgroup, fragment preservation may rival OATS without introducing donor-site risk.

At the larger end of the size spectrum, the threshold at which OATS becomes insufficient and osteochondral allograft (OCA) or ACI/MACI should take over is not robustly defined. Lesion area alone is insufficient as a guide; depth, cyst volume, and whether the defect has a containing cartilage rim all influence the expected result, yet no validated algorithm currently integrates these variables systematically.

Uncontained or shoulder lesions — those without a surrounding cartilage rim — are the least predictable subset regardless of technique. If pre-operative imaging shows cysts, deep bone involvement, or absent containment, patients should raise those specific features at the planning consultation: they are precisely the variables most likely to change the recommended approach.

What the assessment and decision process involves

Accurate planning is the foundation on which the choice between OATS, fragment preservation, retrograde drilling, or a larger-defect alternative rests. The variables that determine the right pathway — defect area relative to the 1.5 cm² threshold, lesion location, cartilage cap integrity, subchondral cyst volume, fragment viability, and the patient's age and activity demands — cannot be established from symptoms alone.

Characterising them requires weight-bearing radiographs alongside dedicated ankle MRI with a protocol that resolves cartilage thickness, bone oedema, and cyst morphology in sufficient detail to inform an operative plan. Open-bore MRI, available at MSK Doctors' Sleaford site, is a practical option for patients who have previously avoided scanning because of claustrophobia.

Consultant assessment then integrates imaging findings, symptom duration, previous treatment history, and realistic functional goals into a decision specific to the individual lesion rather than the average case. No GP referral is needed to begin that process. Consultant-led evaluation without NHS-style waiting lists can be booked directly at mskdoctors.com — and timing is not trivial, since subchondral cyst progression and loss of containment can progressively narrow the surgical options available.

1. [1] Articular cartilage repair. https://en.wikipedia.org/?curid=19042351 https://en.wikipedia.org/?curid=19042351
2. [2] Osteochondritis dissecans. https://en.wikipedia.org/?curid=3762029 https://en.wikipedia.org/?curid=3762029
3. [3] Microfracture surgery. https://en.wikipedia.org/?curid=8840994 https://en.wikipedia.org/?curid=8840994